Raffaelli, Bianca
Fitzek, Mira
Overeem, Lucas H.
Storch, Elisabeth
Terhart, Maria
Reuter, Uwe
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
Article History
Received: 7 November 2022
Accepted: 14 February 2023
First Online: 27 February 2023
Declarations
:
: The study was approved by the Charité Ethical Committee (EA1/159/22). Written informed consent was not required due to the retrospective nature of the study.
: Not applicable.
: R reports research grants from Novartis, and personal fees from Abbvie/Allergan, Hormosan, Lilly, Novartis, and Teva. MF reports personal feed from TEVA. MT reports personal fees from TEVA. UR received honoraria for consulting and lectures from Amgen, Allergan, Abbvie, Eli Lilly, Lundbeck, Novartis, electroCore, Medscape, StreaMedUp, and Teva. UR received research funding from the German Federal Ministry of Education and Research and Novartis. The other authors have nothing to disclose.